Industry ‘Deeply Concerned’ Over Slow Progress With EU Drug Authentication System
Executive Summary
Pharmaceutical industry stakeholders are “deeply concerned” about the slow rate of sign-ups to the future European medicines authentication system, according to the industry federation EFPIA. To encourage more companies to connect as early as possible, the joining fee is to increase this month. There are also wider worries about EU member state implementation of the system.
You may also be interested in...
Europe’s Medicines Verification System Prepares To Go Live
Europe’s ambitious new system for verifying the authenticity of prescription medicines circulating on the market is about to come into operation.
Meet EU Safety Feature Deadline Or Face Penalties, Firms Warned
Pharma firms, distributors and pharmacies have been warned that they need to take action to ensure they are ready for the implementation of Europe's product verification system in February 2019. Brexit, though, has cast uncertainty over the extent of the UK's participation in the new system.
Updated EU Guide On Safety Features Addresses Parallel Trade Repackaging
The EU guideline on complying with the requirement to affix safety features on medicine packs has been updated to address specific aspects of parallel trade, such as re-sealing of medicine packs that are legally opened to replace patient information leaflets.